These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1412158)

  • 61. High-molecular weight kininogen is present in cultured human endothelial cells: localization, isolation, and characterization.
    van Iwaarden F; de Groot PG; Sixma JJ; Berrettini M; Bouma BN
    Blood; 1988 May; 71(5):1268-76. PubMed ID: 3282568
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Monoclonal antibodies against the complex between HMW kininogen and calpain I.
    Ohkubo I; Higashiyama S; Sasaki M
    Adv Exp Med Biol; 1989; 247B():305-10. PubMed ID: 2558507
    [No Abstract]   [Full Text] [Related]  

  • 63. Quantification of kininogens in plasma. A functional method based on the cysteine proteinase inhibitor activity.
    Karlsrud TS; Buø L; Aasen AO; Johansen HT
    Thromb Res; 1996 May; 82(3):265-73. PubMed ID: 8732630
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Isolation and immunologic properties of a heterogeneous antigen with the characteristics of the heavy chain of human plasma kininogen.
    Kärkkäinen T; Syvänen AC; Turpeinen U; Hamberg U
    Mol Immunol; 1982 Jan; 19(1):179-89. PubMed ID: 7043244
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Kinetic analysis of the role of zinc in the interaction of domain 5 of high-molecular weight kininogen (HK) with heparin.
    Lin Y; Pixley RA; Colman RW
    Biochemistry; 2000 May; 39(17):5104-10. PubMed ID: 10819977
    [TBL] [Abstract][Full Text] [Related]  

  • 66. High molecular weight kininogen receptor.
    Greengard JS; Griffin JH
    Methods Enzymol; 1992; 215():369-82. PubMed ID: 1331710
    [No Abstract]   [Full Text] [Related]  

  • 67. Effect of single-chain and two-chain high molecular weight kininogen on adsorption of fibrinogen from binary mixtures to glass and sulfonated polyurethane surfaces.
    Cornelius RM; Brash JL
    J Biomed Mater Res; 1997 Dec; 37(3):314-23. PubMed ID: 9368136
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Lack of clinically significant contact system activation during platelet concentrate filtration by leukocyte removal filters.
    Scott CF; Brandwein H; Whitbread J; Colman RW
    Blood; 1998 Jul; 92(2):616-22. PubMed ID: 9657763
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Structure-function correlates of human high molecular weight kininogen.
    Colman RW
    Braz J Med Biol Res; 1994 Aug; 27(8):1839-53. PubMed ID: 7749373
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Identification of cytokeratin 1 as a binding protein and presentation receptor for kininogens on endothelial cells.
    Hasan AA; Zisman T; Schmaier AH
    Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3615-20. PubMed ID: 9520414
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Monoclonal antibodies against rat T-kininogen: application to radioimmunoassay and immunohistochemistry.
    Utsunomiya I; Oh-ishi S; Hayashi I; Maruhashi J; Tsuji N; Yamamoto N; Yamashina S
    J Biochem; 1988 Feb; 103(2):225-30. PubMed ID: 3372487
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Demonstration of high-molecular-weight kininogen in kininogen-deficient rat kidneys.
    Mimura T; Hayashi I; Hoshino T; Oh-ishi S
    J Biochem; 1994 Jul; 116(1):59-63. PubMed ID: 7798187
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Genetic basis of total kininogen deficiency in Williams' trait.
    Cheung PP; Kunapuli SP; Scott CF; Wachtfogel YT; Colman RW
    J Biol Chem; 1993 Nov; 268(31):23361-5. PubMed ID: 7901207
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mapping the cell binding site on high molecular weight kininogen domain 5.
    Hasan AA; Cines DB; Herwald H; Schmaier AH; Müller-Esterl W
    J Biol Chem; 1995 Aug; 270(33):19256-61. PubMed ID: 7642598
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Kininogen binding to the surfaces of macrophages.
    Barbasz A; Guevara-Lora I; Rapala-Kozik M; Kozik A
    Int Immunopharmacol; 2008 Feb; 8(2):211-6. PubMed ID: 18182229
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Purification and characterization of acute phase rat plasma thiostatin.
    Rusiniak ME; Wagh PV; Bedi GS; Back N
    Prep Biochem; 1994 Feb; 24(1):41-59. PubMed ID: 7514789
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Immunoassay of molecular forms of human plasma kininogen and detection of low Mr fragments of kininogen by means of a conformation-dependent antigenic determinant.
    Hamberg U; Syvanen AC; Karkkainen T
    Adv Exp Med Biol; 1983; 156():175-82. PubMed ID: 6190366
    [No Abstract]   [Full Text] [Related]  

  • 78. Comments on 'Quantification of human high molecular weight kininogen by immunoblotting with a monoclonal anti-light chain antibody' by Reddigari and Kaplan.
    Lämmle B
    J Immunol Methods; 1989 Dec; 125(1-2):291-3. PubMed ID: 2607161
    [No Abstract]   [Full Text] [Related]  

  • 79. Platelet high-molecular-weight kininogen.
    Schmaier AH; Colman RW
    Methods Enzymol; 1989; 169():276-96. PubMed ID: 2654563
    [No Abstract]   [Full Text] [Related]  

  • 80. Evaluation of a microassay for human kininogens as cysteine protease inhibitors.
    Karlsrud TS; Aasen AO; Johansen HT
    J Pharmacol Methods; 1991 Sep; 26(2):113-24. PubMed ID: 1943122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.